June 15, 2026Surface Proteomics for ADCs and CAR-T DesignContinue ReadingJune 02, 2026Advancing the Frontier of Translational Proteomic InsightsContinue ReadingMay 22, 2026A Metabolic Blueprint for Synergistic Cancer TherapyContinue ReadingMay 21, 2026Surface Proteomics for Smarter Drug Target DiscoveryContinue ReadingApril 28, 2026Untargeted Metabolomics Reimagined: Meet MassID™Continue ReadingApril 20, 2026Decoding Alzheimer’s Disease with Multi-OmicsContinue ReadingApril 14, 2026Untargeted vs. Targeted Exposomics Which Do You Need?Continue ReadingApril 10, 2026A Head-to-Head Comparison of Untargeted MetabolomicsContinue ReadingApril 06, 2026The Hidden Metabolic Information of FFPE TissueContinue ReadingMarch 31, 2026Untargeted Metabolomics: Legacy vs. Panome BioContinue ReadingFebruary 27, 2026Why Disease Risk Lives in the ExposomeContinue ReadingJanuary 21, 2026Mechanistic Insights into Functional Foods With MetabolomicsContinue ReadingJanuary 12, 2026Quantitative Metabolomics for Clinical and Translational ResearchContinue ReadingDecember 17, 2025How Untargeted Metabolomics Validates ApoE Knockout Models in ADContinue ReadingDecember 11, 2025Quantifying Host–Microbiome Interactions in Disease ResearchContinue ReadingDecember 10, 2025High-Throughput Metabolomics for Food Composition AnalysisContinue ReadingDecember 10, 2025Multi-Omics Integration with Quantitative MetabolomicsContinue ReadingDecember 05, 2025Metabolomics to Track Nutrient Fate and TransformationContinue ReadingDecember 05, 2025Integrating Untargeted and Quantitative Metabolomics WorkflowsContinue ReadingNovember 25, 2025Untargeted Metabolomics for Dietary Intervention InsightsContinue ReadingNovember 24, 2025Saving PRMT5 Drug Development with MetabolomicsContinue ReadingNovember 24, 2025Metabolic Signatures Reveal Molecular Glue ActivityContinue ReadingNovember 24, 2025Predict Responders in mRNA Trials via MetabolomicsContinue ReadingNovember 24, 2025Metabolomic Logic Behind MAT2A/PRMT5 CombinationsContinue ReadingNovember 07, 2025Beyond Trial and Error: Multi-Omics for Cultured Meat Media OptimizationContinue ReadingNovember 07, 2025Imaging and Metabolomics in Radioligand TherapyContinue ReadingNovember 06, 2025Building Research Credibility with CLIAContinue ReadingNovember 05, 2025Predicting RLT Resistance with Metabolomics and Imaging in MiceContinue ReadingNovember 04, 2025Metabolomics in Alzheimer’s DiseaseContinue ReadingNovember 03, 2025Using Multi-Omics to Study Biological Effects of Natural ProductsContinue ReadingOctober 30, 2025Using Metabolomics and Imaging to Track RLT ResponseContinue ReadingOctober 01, 2025From mRNA to Immunity: Multi-Omics Mechanism of ActionContinue ReadingOctober 01, 2025Mapping Signaling Drivers of Antibody Drug Conjugate ResistanceContinue ReadingSeptember 29, 2025Multi-Omics in Animal Models for Preclinical DiscoveryContinue ReadingSeptember 26, 2025Advancing PROTAC Research with Discovery ProteomicsContinue ReadingSeptember 25, 2025Benchmarking Natural Products with NextGen Metabolomics®Continue ReadingSeptember 25, 2025Beyond SDMA: Comprehensive PRMT5 MetabolomicsContinue ReadingSeptember 25, 2025Improving ADC Research via Surface ProteomicsContinue ReadingSeptember 24, 2025Time-Resolved Multi-Omics Reveals Glue-Driven RemodelingContinue ReadingSeptember 24, 2025Sample Traceability and Research FlexibilityContinue ReadingSeptember 24, 2025Sphingolipid Dysregulation in ApoE Alzheimer’s ModelsContinue ReadingSeptember 24, 2025Future of PROTAC Research: Opportunities and ObstaclesContinue ReadingSeptember 22, 2025FFPE Metabolomics to Multi‑Omics and Precision MedicineContinue ReadingSeptember 21, 2025Solving SAM and MTA Measurement with Isotope StandardsContinue ReadingSeptember 21, 2025PROTACs: Advanced Conjugation StrategiesContinue ReadingSeptember 19, 2025Why Multi-Omics Beats Standard LNP Screening MetricsContinue ReadingSeptember 19, 2025Functional Microbiome Analysis from Taxonomy to ActivityContinue ReadingSeptember 18, 2025Adding Value to Biorepositories with FFPE MetabolomicsContinue ReadingSeptember 16, 2025How Metabolomics Uncovers Lipid Dysregulation in Alzheimer’sContinue ReadingSeptember 16, 2025Metabolomics for Quality Control in Natural Product ResearchContinue ReadingSeptember 16, 2025Decoding RLT Resistance with Multi‑Omics ProfilingContinue ReadingSeptember 16, 2025Why MTAP Alone Falls Short for PRMT5 Patient SelectionContinue ReadingSeptember 16, 2025Extract Biochemical Data from Archived FFPE TissueContinue ReadingSeptember 15, 2025Functional Microbiome Analysis with MetabolomicsContinue ReadingSeptember 13, 2025Beyond Protein Levels: Phosphoproteomics for mRNA TherapiesContinue ReadingSeptember 13, 2025Turn FFPE Blocks into New Discoveries with Next-Gen Metabolomics®Continue ReadingSeptember 12, 2025Decoding Natural Product Biosynthesis with MetabolomicsContinue ReadingSeptember 12, 2025Molecular Profiling in Radioligand Therapy DevelopmentContinue ReadingSeptember 12, 2025Expanding Biomarker Discovery: Metabolomics from FFPE SamplesContinue ReadingSeptember 08, 2025The SDMA and ADMA Measurement ChallengeContinue ReadingSeptember 08, 2025Unbiased Proteomics for Molecular Glue Target DiscoveryContinue ReadingSeptember 08, 2025Is Your mRNA Making the Right Protein? Proteomics Reveals ItContinue ReadingSeptember 02, 2025Understanding the Microbiome Through Its MetabolitesContinue ReadingAugust 22, 2025Transforming Dried Blood Spot Analysis with MetabolomicsContinue ReadingAugust 22, 2025How CLIA Certification Strengthens Research QualityContinue ReadingLoad More
